New Combo Therapy Extends Survival By More Than A Year In Advanced Triple Positive Breast Cancers

WEDNESDAY, Feb. 4, 2026 — Taking one additional pill could buy more than an extra year of precious time for people with advanced breast cancer, a new clinical trial showed.Adding the targeted drug palbociclib (Ibrance) to existing therapies added 1...